CD8A and neoplasm: The baseline density and location of CD8+ T cells at the margin or the core of tumor, and the pre‐existing CD8 T cells that are negatively regulated by PD‐1/PD‐L1 could determine antitumor activity by PD‐1 immune checkpoints.18